Scriba, Thomas J.
South African Tuberculosis Vaccine Initiative,
South Africa
2025 Rank: 189529
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Microbiology
Rank in SubField 1: 3335 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 189529 | 186725 |
| Total Cites | 931 | 1058 |
| H-index | 14 | 16 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 56 | 63 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 166 | 182 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 627 | 682 |
| Ratio of Total Citations to Distinct Citing Papers | 1.48 | 1.55 |
| Self-Citation Percentage |
12.00%
|
|
Scriba, Thomas J.
University of Cape Town,
South Africa
2024 Rank: 147390
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Microbiology
Rank in SubField 1: 2779 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 147390 | 151542 |
| Total Cites | 1081 | 1210 |
| H-index | 17 | 18 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 51 | 55 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 184 | 199 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 701 | 744 |
| Ratio of Total Citations to Distinct Citing Papers | 1.54 | 1.63 |
| Self-Citation Percentage |
10.66%
|
|
Scriba, Thomas J.
University of Cape Town,
South Africa
2023 Rank: 151802
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Microbiology
Rank in SubField 1: 3106 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 151802 | 138313 |
| Total Cites | 1091 | 1269 |
| H-index | 15 | 18 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 59 | 67 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 193 | 218 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 712 | 769 |
| Ratio of Total Citations to Distinct Citing Papers | 1.53 | 1.65 |
| Self-Citation Percentage |
14.03%
|
|
Scriba, Thomas J.
South African Tuberculosis Vaccine Initiative,
South Africa
2022 Rank: 116139
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Microbiology
Rank in SubField 1: 2681 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 116139 | 111438 |
| Total Cites | 1205 | 1461 |
| H-index | 18 | 20 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 61 | 74 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 224 | 261 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 787 | 879 |
| Ratio of Total Citations to Distinct Citing Papers | 1.53 | 1.66 |
| Self-Citation Percentage |
17.52%
|
|
Scriba, Thomas J.
South African Tuberculosis Vaccine Initiative,
South Africa
2021 Rank: 112921
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Microbiology
Rank in SubField 1: 2427 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 112921 | 96413 |
| Total Cites | 1935 | 2384 |
| H-index | 23 | 27 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 98 | 127 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 342 | 416 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1245 | 1374 |
| Ratio of Total Citations to Distinct Citing Papers | 1.55 | 1.74 |
| Self-Citation Percentage |
18.83%
|
|
Scriba, Thomas J.
South African Tuberculosis Vaccine Initiative,
South Africa
2020 Rank: 116681
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Microbiology
Rank in SubField 1: 2352 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 116681 | 94680 |
| Total Cites | 1355 | 1784 |
| H-index | 19 | 22 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 86 | 112 |
| Number of Single+First+Last Authored Papers | 35 | 35 |
| Total Cites to Single+First+Last Authored Papers | 202 | 268 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 806 | 923 |
| Ratio of Total Citations to Distinct Citing Papers | 1.68 | 1.93 |
| Self-Citation Percentage |
24.05%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.